Prognostic factors for worsening and improvement in multiple sclerosis using a multi-state model by Ocampo, A, Hatami, F, Čuklina, J, Ganjgahi, H, Sun, Y, Gardiner, S, Pendleton, S, Haring, D, Nichols, T, Wiendl, H

Characterisation of MS phenotypes across the age span using a novel data set integrating 34 clinical trials (NO.MS cohort): age is a key contributor to presentation by Dahlke, F, Arnold, DL, Aarden, P, Ganjgahi, H, Häring, DA, Čuklina, J, Nichols, TE, Gardiner, S, Bermel, R, Wiendl, H

How patients with multiple sclerosis acquire disability by Lublin, FD, Häring, DA, Ganjgahi, H, Ocampo, A, Hatami, F, Čuklina, J, Aarden, P, Dahlke, F, Arnold, DL, Wiendl, H, Chitnis, T, Nichols, TE, Kieseier, BC, Bermel, RA